Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Ambros J. Beer, Sarah M. Schwarzenböck, Niko Zantl, Michael Souvatzoglou, Tobias Maurer, Petra Watzlowik, Horst Kessler, Hans-Jürgen Wester, Markus Schwaiger, Bernd Joachim Krause
Published Apr 6, 2016 · Vol. 7, No. 19 · pp. 28151-28159
Daniel R. Principe, Brian DeCant, Andrew M. Diaz, Riley J. Mangan, Rosa Hwang, Andrew Lowy, Brandon B. Shetuni, Bharath K. Sreekumar, Chuhan Chung, David J. Bentrem, Hidayatullah G. Munshi, Barbara Jung, Paul J. Grippo, Faraz Bishehsari
Published Apr 5, 2016 · Vol. 7, No. 19 · pp. 28218-28234
Wan Li, Xuemei Jia, Chenyou Shen, Mi Zhang, Jingyun Xu, Yuancui Shang, Kaixiang Zhu, Minmin Hu, Qin Yan, Di Qin, Myung-Shin Lee, Jianzhong Zhu, Hongmei Lu, Brian J. Krueger, Rolf Renne, Shou-Jiang Gao, Chun Lu
Published Apr 5, 2016 · Vol. 7, No. 22 · pp. 32286-32305